Cycloserine microbiology

Cycloserine

SEROMYCIN ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Chetan Lokhande, M.B.B.S [2]

## Microbiology

[edit | edit source]

Cycloserine inhibits cell–wall synthesis in susceptible strains of Gram positive and Gram negative bacteria and in Mycobacterium tuberculosis.

#### Susceptibility Tests

[edit | edit source]

Cycloserine clinical laboratory standard powder is available for both direct and indirect methods1 of determining the susceptibility of strains of mycobacteria. Cycloserine MICs for susceptible strains are 25 μg/mL or lower.[1]

## References

[edit | edit source]

1. ↑ "SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER]". Text " accessdate " ignored (help)

Adapted from the FDA Package Insert.